Table 2.
Variable | No diabetes (n = 134) | Diabetes (n = 67) | p value |
---|---|---|---|
Concomitant procedures | |||
Mitral valve procedure, n | 22 (16.4%) | 9 (13.4%) | 0.58 |
Tricuspid valvuloplasty, n | 15 (11.2%^) | 7 (10.4%) | 0.87 |
CABG, n | 6 (4.5%) | 8 (11.9%) | 0.05 |
Maze procedure, n | 5 (3.7%) | 8 (11.9%) | 0.03 |
Cardiopulmonary bypass time, min | 107.6 ± 47.1 | 113.3 ± 51.2 | 0.43 |
Aortic crossclamping time, min | 72.7 ± 36.4 | 76.8 ± 35.9 | 0.45 |
Postoperative ventilation time, min | 17.0 (13.0–21.0) | 17.0 (13.0–24.0) | 0.98 |
Postoperative hospital stays, day | 8.4 ± 3.8 | 8.4 ± 4.2 | 0.96 |
Post-operative LVOT gradient, mmHg | 6.6 ± 2.7 | 7.6 ± 3.4 | 0.04 |
Perioperative death | 0 (0.0%) | 1 (1.5%) | 0.33 |
Values are presented as percentage, mean ± SD, or median (interquartile range) when appropriate
CABG coronary artery bypass graft, ICU intensive care unit